Cargando…
Protective antibodies against human parainfluenza virus type 3 infection
Human parainfluenza virus type III (HPIV3) is a common respiratory pathogen that afflicts children and can be fatal in vulnerable populations, including the immunocompromised. There are currently no effective vaccines or therapeutics available, resulting in tens of thousands of hospitalizations per...
Autores principales: | Boonyaratanakornkit, Jim, Singh, Suruchi, Weidle, Connor, Rodarte, Justas, Bakthavatsalam, Ramasamy, Perkins, Jonathan, Stewart-Jones, Guillaume B.E., Kwong, Peter D., McGuire, Andrew T., Pancera, Marie, Taylor, Justin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078717/ https://www.ncbi.nlm.nih.gov/pubmed/33876699 http://dx.doi.org/10.1080/19420862.2021.1912884 |
Ejemplares similares
-
Cross-protective antibodies against common endemic respiratory viruses
por: Cabán, Madelyn, et al.
Publicado: (2023) -
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core
por: Borst, Andrew J, et al.
Publicado: (2018) -
Alix Serves as an Adaptor That Allows Human Parainfluenza Virus Type 1 to Interact with the Host Cell ESCRT System
por: Boonyaratanakornkit, Jim, et al.
Publicado: (2013) -
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies
por: Seydoux, Emilie, et al.
Publicado: (2021) -
Anti-idiotypic antibodies elicit anti-HIV-1–specific B cell responses
por: Dosenovic, Pia, et al.
Publicado: (2019)